U-Blot® Research Grade Anti-Human APP/Amyloid beta (MEDI8490)Cat. No. WA1180Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade Anti-Human APP/Amyloid beta (MEDI8490)Cat. No. WA1180
U-Blot® Research Grade Anti-Human APP/Amyloid beta (MEDI1814)Cat. No. WA1179
U-Blot® Research Grade Anti-Human APP/Amyloid beta (KHK6640)Cat. No. WA1178
U-Blot® Research Grade Anti-Human APP/Amyloid beta (GSK 933776)Cat. No. WA1177
U-Blot® Research Grade Anti-Human APP/Amyloid beta (DLX212)Cat. No. WA1176
U-Blot® Research Grade Anti-Human APP/Amyloid beta (CNTO 2125)Cat. No. WA1175
U-Blot® Research Grade Anti-Human APP/Amyloid beta (C705)Cat. No. WA1174
U-Blot® Research Grade Anti-Human APP/Amyloid beta (BI 1034020)Cat. No. WA1173
U-Blot® Research Grade Anti-Human APP/Amyloid beta (AD0802)Cat. No. WA1172
U-Blot® Research Grade Anti-Human APP/Amyloid beta (ABvac42)Cat. No. WA1171
U-Blot® Research Grade Anti-Human APP/Amyloid beta (ABvac40)Cat. No. WA1170
U-Blot® Research Grade Anti-Human APP/Amyloid beta (AAB-003)Cat. No. WA1169